Skip to main content
Erschienen in: Diabetologia 1/2015

01.01.2015 | Article

Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts

verfasst von: Akram Alyass, Peter Almgren, Mikael Akerlund, Jonathan Dushoff, Bo Isomaa, Peter Nilsson, Tiinamaija Tuomi, Valeriya Lyssenko, Leif Groop, David Meyre

Erschienen in: Diabetologia | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The relevance of the OGTT in predicting type 2 diabetes is unclear. We assessed the performance of 14 OGTT glucose traits in type 2 diabetes prediction.

Methods

We studied 2,603 and 2,386 Europeans from the Botnia study and Malmö Prevention Project (MPP) cohorts with baseline OGTT data. Over a follow-up period of 4.94 years and 23.5 years, 155 (5.95%) and 467 (19.57%) participants, respectively, developed type 2 diabetes. The main outcome was incident type 2 diabetes.

Results

One-hour plasma glucose (1h-PG) was a fair/good predictor of incident type 2 diabetes in the Botnia study and MPP (AUC for receiver operating characteristic [AUCROC] 0.80 [0.77, 0.84] and 0.70 [0.68, 0.73]). 1h-PG alone outperformed the prediction model of multiple clinical risk factors (age, sex, BMI, family history of type 2 diabetes) in the Botnia study and MPP (AUCROC 0.75 [0.72, 0.79] and 0.67 [0.64, 0.70]). The same clinical risk factors added to 1h-PG modestly increased prediction for incident type 2 diabetes (Botnia, AUCROC 0.83 [0.80, 0.86]; MPP, AUCROC 0.74 [0.72, 0.77]). 1h-PG also outperformed HbA1c in predicting type 2 diabetes in the Botnia cohort. A 1h-PG value of 8.9 mmol/l and 8.4 mmol/l was the optimal cut-point for initial screening and selection of high-risk individuals in the Botnia study and MPP, respectively, and represented 30% and 37% of all participants in these cohorts. High-risk individuals had a substantially increased risk of incident type 2 diabetes (OR 8.0 [5.5, 11.6] and 3.8 [3.1, 4.7]) and captured 75% and 62% of all incident type 2 diabetes in the Botnia study and MPP.

Conclusions/interpretation

1h-PG is a valuable prediction tool for identifying adults at risk for future type 2 diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat ADA Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197 ADA Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197
2.
Zurück zum Zitat Chen L, Magliano DJ, Zimmet PZ (2011) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 8:228–236PubMedCrossRef Chen L, Magliano DJ, Zimmet PZ (2011) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 8:228–236PubMedCrossRef
3.
Zurück zum Zitat Fox CS, Coady S, Sorlie PD et al (2007) Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 115:1544–1550PubMedCrossRef Fox CS, Coady S, Sorlie PD et al (2007) Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 115:1544–1550PubMedCrossRef
4.
Zurück zum Zitat Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579PubMedCrossRef Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579PubMedCrossRef
5.
Zurück zum Zitat Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591PubMedCrossRef Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591PubMedCrossRef
6.
Zurück zum Zitat Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF (2003) Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884–1890PubMedCrossRef Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF (2003) Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884–1890PubMedCrossRef
7.
Zurück zum Zitat Gang H, Hai Y, Dhingra R et al (2011) A novel hypoxia-inducible spliced variant of mitochondrial death gene Bnip3 promotes survival of ventricular myocytes. Circ Res 108:1084–1092PubMedCrossRef Gang H, Hai Y, Dhingra R et al (2011) A novel hypoxia-inducible spliced variant of mitochondrial death gene Bnip3 promotes survival of ventricular myocytes. Circ Res 108:1084–1092PubMedCrossRef
9.
Zurück zum Zitat Merlotti C, Morabito A, Pontiroli AE (2014) Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab 16:719–727PubMedCrossRef Merlotti C, Morabito A, Pontiroli AE (2014) Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab 16:719–727PubMedCrossRef
10.
Zurück zum Zitat Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef
12.
Zurück zum Zitat Collins GS, de Groot JA, Dutton S et al (2014) External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol 14:40PubMedCentralPubMedCrossRef Collins GS, de Groot JA, Dutton S et al (2014) External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol 14:40PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Kodama S, Horikawa C, Fujihara K et al (2013) Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis. Diabetes Metab Res Rev 29:680–692PubMedCrossRef Kodama S, Horikawa C, Fujihara K et al (2013) Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis. Diabetes Metab Res Rev 29:680–692PubMedCrossRef
14.
Zurück zum Zitat Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L (2009) Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 32:281–286PubMedCentralPubMedCrossRef Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L (2009) Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 32:281–286PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Rathmann W, Kowall B, Heier M et al (2010) Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study. Diabet Med 27:1116–1123PubMedCrossRef Rathmann W, Kowall B, Heier M et al (2010) Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study. Diabet Med 27:1116–1123PubMedCrossRef
16.
Zurück zum Zitat Abdul-Ghani MA, Lyssenko V, Tuomi T, Defronzo RA, Groop L (2010) The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diabetes Metab Res Rev 26:280–286PubMedCrossRef Abdul-Ghani MA, Lyssenko V, Tuomi T, Defronzo RA, Groop L (2010) The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diabetes Metab Res Rev 26:280–286PubMedCrossRef
17.
Zurück zum Zitat Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A (2011) Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? Am J Physiol Regul Integr Comp Physiol 300:R941–R948PubMedCrossRef Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A (2011) Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? Am J Physiol Regul Integr Comp Physiol 300:R941–R948PubMedCrossRef
18.
Zurück zum Zitat Kanauchi M, Kimura K, Kanauchi K, Saito Y (2005) Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals. Int J Clin Pract 59:427–432PubMedCrossRef Kanauchi M, Kimura K, Kanauchi K, Saito Y (2005) Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals. Int J Clin Pract 59:427–432PubMedCrossRef
19.
Zurück zum Zitat Tschritter O, Fritsche A, Shirkavand F, Machicao F, Haring H, Stumvoll M (2003) Assessing the shape of the glucose curve during an oral glucose tolerance test. Diabetes Care 26:1026–1033PubMedCrossRef Tschritter O, Fritsche A, Shirkavand F, Machicao F, Haring H, Stumvoll M (2003) Assessing the shape of the glucose curve during an oral glucose tolerance test. Diabetes Care 26:1026–1033PubMedCrossRef
20.
Zurück zum Zitat Froslie KF, Roislien J, Qvigstad E et al (2013) Shape information from glucose curves: functional data analysis compared with traditional summary measures. BMC Med Res Methodol 13:6PubMedCentralPubMedCrossRef Froslie KF, Roislien J, Qvigstad E et al (2013) Shape information from glucose curves: functional data analysis compared with traditional summary measures. BMC Med Res Methodol 13:6PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220–2232PubMedCrossRef Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220–2232PubMedCrossRef
22.
Zurück zum Zitat Genter PM, Ipp E (1994) Accuracy of plasma glucose measurements in the hypoglycemic range. Diabetes Care 17:595–598PubMedCrossRef Genter PM, Ipp E (1994) Accuracy of plasma glucose measurements in the hypoglycemic range. Diabetes Care 17:595–598PubMedCrossRef
23.
Zurück zum Zitat Sonowane M, Savory J, Cross RE, Heintges MG, Chester B (1976) Kinetic measurement of glucose with a centrifugal analyzer; hexokinase and glucose oxidase procedures compared. Clin Chem 22:1100–1101PubMed Sonowane M, Savory J, Cross RE, Heintges MG, Chester B (1976) Kinetic measurement of glucose with a centrifugal analyzer; hexokinase and glucose oxidase procedures compared. Clin Chem 22:1100–1101PubMed
24.
Zurück zum Zitat (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1): S62–S69 (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1): S62–S69
25.
Zurück zum Zitat Rolandsson O, Hagg E, Nilsson M, Hallmans G, Mincheva-Nilsson L, Lernmark A (2001) Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. J Intern Med 249:279–288PubMedCrossRef Rolandsson O, Hagg E, Nilsson M, Hallmans G, Mincheva-Nilsson L, Lernmark A (2001) Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. J Intern Med 249:279–288PubMedCrossRef
26.
Zurück zum Zitat Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M (2007) What is the best predictor of future type 2 diabetes? Diabetes Care 30:1544–1548PubMedCrossRef Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M (2007) What is the best predictor of future type 2 diabetes? Diabetes Care 30:1544–1548PubMedCrossRef
27.
Zurück zum Zitat Song SH, Hardisty CA (2009) Early onset type 2 diabetes mellitus: a harbinger for complications in later years—clinical observation from a secondary care cohort. QJM 102:799–806PubMedCrossRef Song SH, Hardisty CA (2009) Early onset type 2 diabetes mellitus: a harbinger for complications in later years—clinical observation from a secondary care cohort. QJM 102:799–806PubMedCrossRef
28.
Zurück zum Zitat Almgren P, Lehtovirta M, Isomaa B et al (2011) Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 54:2811–2819PubMedCrossRef Almgren P, Lehtovirta M, Isomaa B et al (2011) Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 54:2811–2819PubMedCrossRef
29.
Zurück zum Zitat Manco M, Panunzi S, Macfarlane DP et al (2010) One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care 33:2090–2097PubMedCentralPubMedCrossRef Manco M, Panunzi S, Macfarlane DP et al (2010) One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care 33:2090–2097PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Marini MA, Succurro E, Frontoni S et al (2012) Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. Diabetes Care 35:868–872PubMedCentralPubMedCrossRef Marini MA, Succurro E, Frontoni S et al (2012) Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. Diabetes Care 35:868–872PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116PubMedCentralPubMedCrossRef Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Saxena R, Hivert MF, Langenberg C et al (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42:142–148PubMedCentralPubMedCrossRef Saxena R, Hivert MF, Langenberg C et al (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42:142–148PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Stern MP, Williams K, Haffner SM (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575–581PubMedCrossRef Stern MP, Williams K, Haffner SM (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575–581PubMedCrossRef
34.
Zurück zum Zitat Gerstein HC, Santaguida P, Raina P et al (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78:305–312PubMedCrossRef Gerstein HC, Santaguida P, Raina P et al (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78:305–312PubMedCrossRef
35.
Zurück zum Zitat Investigators DT, Gerstein HC, Yusuf S et al (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096–1105CrossRef Investigators DT, Gerstein HC, Yusuf S et al (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096–1105CrossRef
36.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef
37.
Zurück zum Zitat Boyko EJ, Gerstein HC, Mohan V et al (2010) Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabet Med 27:1226–1232PubMedCrossRef Boyko EJ, Gerstein HC, Mohan V et al (2010) Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabet Med 27:1226–1232PubMedCrossRef
38.
Zurück zum Zitat Abdul-Ghani MA, Abdul-Ghani T, Ali N, DeFronzo RA (2008) One hour plasma glucose concentration and the metabolic syndrome identifies subjects at high risk for future type 2 diabetes. Diabetes Care 31:1650–1655PubMedCentralPubMedCrossRef Abdul-Ghani MA, Abdul-Ghani T, Ali N, DeFronzo RA (2008) One hour plasma glucose concentration and the metabolic syndrome identifies subjects at high risk for future type 2 diabetes. Diabetes Care 31:1650–1655PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Matyka KA (2008) Type 2 diabetes in childhood: epidemiological and clinical aspects. Br Med Bull 86:59–75PubMedCrossRef Matyka KA (2008) Type 2 diabetes in childhood: epidemiological and clinical aspects. Br Med Bull 86:59–75PubMedCrossRef
40.
Zurück zum Zitat Lijmer JG, Bossuyt PM (2009) Various randomized designs can be used to evaluate medical tests. J Clin Epidemiol 62:364–373PubMedCrossRef Lijmer JG, Bossuyt PM (2009) Various randomized designs can be used to evaluate medical tests. J Clin Epidemiol 62:364–373PubMedCrossRef
41.
Zurück zum Zitat Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinforma 12:77CrossRef Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinforma 12:77CrossRef
Metadaten
Titel
Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts
verfasst von
Akram Alyass
Peter Almgren
Mikael Akerlund
Jonathan Dushoff
Bo Isomaa
Peter Nilsson
Tiinamaija Tuomi
Valeriya Lyssenko
Leif Groop
David Meyre
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 1/2015
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3390-x

Weitere Artikel der Ausgabe 1/2015

Diabetologia 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.